- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
112
112 companies
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.4b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥16.65
7D
-1.8%
1Y
24.8%
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€77.85
7D
-4.8%
1Y
174.7%
Elicera Therapeutics
Market Cap: SEK 103.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.95
7D
31.1%
1Y
126.1%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩29,500.00
7D
1.4%
1Y
4.4%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩335,500.00
7D
-0.6%
1Y
195.3%
RemeGen
Market Cap: HK$21.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$26.50
7D
19.1%
1Y
-9.6%
Devyser Diagnostics
Market Cap: SEK 1.6b
Develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 96.00
7D
-9.9%
1Y
-7.7%
Bonesupport Holding
Market Cap: SEK 20.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 316.40
7D
5.3%
1Y
34.9%
Acrux
Market Cap: AU$9.3m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.022
7D
-4.3%
1Y
-68.1%
ALTEOGEN
Market Cap: ₩19.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩363,000.00
7D
3.0%
1Y
125.5%
Neuland Laboratories
Market Cap: ₹154.4b
Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹12,037.35
7D
0.1%
1Y
85.2%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥12.6b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥57.20
7D
-7.3%
1Y
6.9%
Akeso
Market Cap: HK$77.1b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$85.90
7D
21.1%
1Y
88.4%
Botanix Pharmaceuticals
Market Cap: AU$775.9m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.40
7D
-13.0%
1Y
70.2%
BioArctic
Market Cap: SEK 15.5b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 175.50
7D
-3.6%
1Y
-16.6%
Clene
Market Cap: US$25.8m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$3.05
7D
-4.1%
1Y
-63.9%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥28.9b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥109.00
7D
13.2%
1Y
112.1%
Telix Pharmaceuticals
Market Cap: AU$8.6b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.
TLX
AU$23.63
7D
-14.7%
1Y
89.6%
Ascentage Pharma Group International
Market Cap: HK$15.6b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$45.40
7D
13.4%
1Y
163.3%
PharmaResources (Shanghai)
Market Cap: CN¥4.3b
Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.
301230
CN¥31.52
7D
-0.2%
1Y
8.9%
Boji Medical TechnologyLtd
Market Cap: CN¥3.9b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.27
7D
4.7%
1Y
37.7%
Ocumension Therapeutics
Market Cap: HK$4.2b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$5.19
7D
5.5%
1Y
-9.4%
Corcept Therapeutics
Market Cap: US$8.8b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$79.37
7D
40.0%
1Y
216.8%
OS Therapies
Market Cap: US$32.1m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.54
7D
-4.9%
1Y
n/a
Silence Therapeutics
Market Cap: US$136.5m
A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$2.74
7D
-25.7%
1Y
-87.2%
Checkpoint Therapeutics
Market Cap: US$338.4m
A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.04
7D
0.2%
1Y
116.0%
ARS Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops treatments for severe allergic reactions.
SPRY
US$13.40
7D
6.1%
1Y
40.6%
Clinuvel Pharmaceuticals
Market Cap: AU$546.9m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.54
7D
-9.8%
1Y
-33.8%
Little Green Pharma
Market Cap: AU$36.3m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.12
7D
-4.0%
1Y
-14.3%
Aether Industries
Market Cap: ₹109.8b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹818.80
7D
-1.5%
1Y
-3.0%
Beijing Hotgen Biotech
Market Cap: CN¥9.6b
Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.
688068
CN¥107.28
7D
16.7%
1Y
241.7%
Jiangsu Jibeier Pharmaceutical
Market Cap: CN¥5.0b
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
688566
CN¥25.13
7D
5.5%
1Y
1.2%
CollPlant Biotechnologies
Market Cap: US$29.5m
A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
CLGN
US$2.46
7D
-7.2%
1Y
-53.2%
Biofrontera
Market Cap: US$7.1m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.79
7D
-7.1%
1Y
-53.7%
Aelis Farma
Market Cap: €16.3m
A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.
AELIS
€1.20
7D
-1.6%
1Y
-90.8%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.2b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥21.99
7D
2.2%
1Y
-19.6%